CA2029705A1 - Resolution enzymatique de l'endo-bicyclo¬2.2.1|heptan-2-ol et d'agents pharmaceutiques derives - Google Patents
Resolution enzymatique de l'endo-bicyclo¬2.2.1|heptan-2-ol et d'agents pharmaceutiques derivesInfo
- Publication number
- CA2029705A1 CA2029705A1 CA2029705A CA2029705A CA2029705A1 CA 2029705 A1 CA2029705 A1 CA 2029705A1 CA 2029705 A CA2029705 A CA 2029705A CA 2029705 A CA2029705 A CA 2029705A CA 2029705 A1 CA2029705 A1 CA 2029705A1
- Authority
- CA
- Canada
- Prior art keywords
- endo
- bicyclo
- heptan
- pharmaceutical agents
- enzymatic resolution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 title 1
- 230000002255 enzymatic effect Effects 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- ZQTYQMYDIHMKQB-DSYKOEDSSA-N (1r,3r,4s)-bicyclo[2.2.1]heptan-3-ol Chemical compound C1C[C@@H]2[C@H](O)C[C@H]1C2 ZQTYQMYDIHMKQB-DSYKOEDSSA-N 0.000 abstract 1
- 102000019280 Pancreatic lipases Human genes 0.000 abstract 1
- 108050006759 Pancreatic lipases Proteins 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229940116369 pancreatic lipase Drugs 0.000 abstract 1
- 238000005809 transesterification reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US89/05228 | 1989-11-13 | ||
| PCT/US1989/005228 WO1991007501A1 (fr) | 1989-11-13 | 1989-11-13 | Resolution enzymatique de endo-bicyclo[2.2.1]heptane-2-ol et agents pharmaceutiques derives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2029705A1 true CA2029705A1 (fr) | 1991-05-14 |
| CA2029705C CA2029705C (fr) | 1998-11-24 |
Family
ID=22215375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002029705A Expired - Fee Related CA2029705C (fr) | 1989-11-13 | 1990-11-09 | Resolution enzymatique de l'endo-bicyclo¬2.2.1|heptan-2-ol et d'agents pharmaceutiques derives |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP0428302B1 (fr) |
| JP (1) | JPH06104661B2 (fr) |
| KR (1) | KR930004654B1 (fr) |
| CN (1) | CN1040423C (fr) |
| AT (1) | ATE158577T1 (fr) |
| AU (3) | AU633157B2 (fr) |
| CA (1) | CA2029705C (fr) |
| CZ (2) | CZ280006B6 (fr) |
| DE (1) | DE69031487T2 (fr) |
| DK (1) | DK0428302T3 (fr) |
| EG (1) | EG19860A (fr) |
| ES (1) | ES2107420T3 (fr) |
| FI (1) | FI105106B (fr) |
| GR (1) | GR3025196T3 (fr) |
| HU (2) | HU220962B1 (fr) |
| IE (2) | IE904059A1 (fr) |
| IL (5) | IL110564A (fr) |
| MY (1) | MY104517A (fr) |
| NO (1) | NO304838B1 (fr) |
| NZ (1) | NZ236037A (fr) |
| PH (1) | PH30255A (fr) |
| PL (4) | PL165132B1 (fr) |
| PT (1) | PT95855B (fr) |
| RU (1) | RU2104306C1 (fr) |
| WO (1) | WO1991007501A1 (fr) |
| YU (1) | YU48413B (fr) |
| ZA (1) | ZA909044B (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991007501A1 (fr) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Resolution enzymatique de endo-bicyclo[2.2.1]heptane-2-ol et agents pharmaceutiques derives |
| US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| IE71647B1 (en) | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
| US5459067A (en) * | 1991-12-06 | 1995-10-17 | Shionogi Seiyaku Kabushiki Kaisha | Method for producing optically active norborneol by ester hydrolysis |
| US5814651A (en) * | 1992-12-02 | 1998-09-29 | Pfizer Inc. | Catechol diethers as selective PDEIV inhibitors |
| AU673569B2 (en) * | 1992-12-02 | 1996-11-14 | Pfizer Inc. | Catechol diethers as selective PDE-IV inhibitors |
| JP3431204B2 (ja) * | 1993-04-22 | 2003-07-28 | 塩野義製薬株式会社 | ノルボルナン型エステル・ヒドロラーゼ |
| CN1041436C (zh) * | 1993-05-07 | 1998-12-30 | 佛山市制药一厂 | 一种稳定冯了性风湿跌打药酒的方法 |
| US5482944A (en) * | 1993-07-13 | 1996-01-09 | Pfizer Inc. | Pyrimidones and imidazolinones for treatment of shock |
| JPH1142095A (ja) * | 1997-07-25 | 1999-02-16 | Chisso Corp | 新規なオキソジシクロペンタジエンの製造方法 |
| KR100479019B1 (ko) * | 1998-05-22 | 2005-08-29 | 씨제이 주식회사 | 캐테콜히드라존유도체,이의제조방법및그를함유한약제학적조성물 |
| TR200909479T2 (tr) | 1999-08-21 | 2012-02-21 | Nycomed Gmbh | Sinerjistik kombinasyon. |
| DE60124616T2 (de) * | 2000-05-08 | 2007-09-13 | Pfizer Products Inc., Groton | Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors |
| WO2003002511A1 (fr) | 2001-06-29 | 2003-01-09 | Nikken Chemicals Co., Ltd. | Derive de cycloalcenone |
| ES2194588B1 (es) * | 2001-07-13 | 2004-10-16 | Astur Pharma S.A. | Precursores opticamente puros de paroxetina. |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| MXPA05010373A (es) | 2003-04-01 | 2005-12-05 | Applied Research Systems | Inhibidores de fosfodiesterasas en infertilidad. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CN103601792B (zh) | 2007-06-04 | 2016-06-29 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
| AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| MX357121B (es) | 2011-03-01 | 2018-06-27 | Synergy Pharmaceuticals Inc Star | Proceso de preparacion de agonistas c de guanilato ciclasa. |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151206A1 (fr) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonistes de la guanylate cyclase et leurs utilisations |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP4424697A3 (fr) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Agonistes ultra-purs de guanylate cyclase c, leur procédé de fabrication et d'utilisation |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261995A (en) * | 1979-08-31 | 1981-04-14 | Syntex (U.S.A.) Inc. | 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives |
| US4732853A (en) * | 1984-11-21 | 1988-03-22 | President And Fellows Of Harvard College | Method of making chiral epoxy alcohols |
| FI875724L (fi) * | 1986-04-29 | 1987-12-28 | Pfizer | Av kalcium oberoende camp fosfodiesteras-inhibitordepressant. |
| WO1991007501A1 (fr) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Resolution enzymatique de endo-bicyclo[2.2.1]heptane-2-ol et agents pharmaceutiques derives |
-
1989
- 1989-11-13 WO PCT/US1989/005228 patent/WO1991007501A1/fr not_active Ceased
- 1989-11-13 HU HU9802988A patent/HU220962B1/hu not_active IP Right Cessation
- 1989-11-13 RU SU5052372A patent/RU2104306C1/ru not_active IP Right Cessation
- 1989-11-13 CZ CS921240A patent/CZ280006B6/cs not_active IP Right Cessation
- 1989-11-13 HU HUP9201587A patent/HU215441B/hu not_active IP Right Cessation
-
1990
- 1990-11-02 EP EP90312019A patent/EP0428302B1/fr not_active Expired - Lifetime
- 1990-11-02 DK DK90312019.4T patent/DK0428302T3/da active
- 1990-11-02 AT AT90312019T patent/ATE158577T1/de not_active IP Right Cessation
- 1990-11-02 EP EP97103886A patent/EP0801135A1/fr not_active Ceased
- 1990-11-02 ES ES90312019T patent/ES2107420T3/es not_active Expired - Lifetime
- 1990-11-02 DE DE69031487T patent/DE69031487T2/de not_active Expired - Fee Related
- 1990-11-06 IL IL110564A patent/IL110564A/en active IP Right Grant
- 1990-11-06 IL IL11056890A patent/IL110568A/en active IP Right Grant
- 1990-11-06 IL IL9626190A patent/IL96261A/en active IP Right Grant
- 1990-11-09 CA CA002029705A patent/CA2029705C/fr not_active Expired - Fee Related
- 1990-11-11 EG EG67090A patent/EG19860A/xx active
- 1990-11-12 PL PL90301764A patent/PL165132B1/pl unknown
- 1990-11-12 NZ NZ236037A patent/NZ236037A/en unknown
- 1990-11-12 PT PT95855A patent/PT95855B/pt not_active IP Right Cessation
- 1990-11-12 ZA ZA909044A patent/ZA909044B/xx unknown
- 1990-11-12 CN CN90109076A patent/CN1040423C/zh not_active Expired - Fee Related
- 1990-11-12 PL PL90292069A patent/PL164202B1/pl unknown
- 1990-11-12 MY MYPI90001992A patent/MY104517A/en unknown
- 1990-11-12 PL PL90287727A patent/PL164176B1/pl unknown
- 1990-11-12 IE IE405990A patent/IE904059A1/en not_active IP Right Cessation
- 1990-11-12 KR KR1019900018244A patent/KR930004654B1/ko not_active Expired - Fee Related
- 1990-11-12 IE IE19980174A patent/IE980174A1/en not_active IP Right Cessation
- 1990-11-12 AU AU66535/90A patent/AU633157B2/en not_active Ceased
- 1990-11-12 PL PL90292070A patent/PL164457B1/pl unknown
- 1990-11-12 YU YU214290A patent/YU48413B/sh unknown
- 1990-11-13 CZ CS905609A patent/CZ280011B6/cs not_active IP Right Cessation
- 1990-11-13 JP JP2306942A patent/JPH06104661B2/ja not_active Expired - Fee Related
-
1992
- 1992-05-12 NO NO921876A patent/NO304838B1/no unknown
- 1992-05-12 FI FI922142A patent/FI105106B/fi not_active IP Right Cessation
-
1993
- 1993-01-22 AU AU31979/93A patent/AU645449B2/en not_active Ceased
- 1993-02-09 AU AU32920/93A patent/AU3292093A/en not_active Withdrawn
- 1993-10-12 PH PH47065A patent/PH30255A/en unknown
-
1994
- 1994-08-04 IL IL11056494A patent/IL110564A0/xx unknown
- 1994-08-04 IL IL11056894A patent/IL110568A0/xx unknown
-
1997
- 1997-10-29 GR GR970402831T patent/GR3025196T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2029705A1 (fr) | Resolution enzymatique de l'endo-bicyclo¬2.2.1|heptan-2-ol et d'agents pharmaceutiques derives | |
| CA2311756A1 (fr) | Reduction de la pousse des poils | |
| AU4731596A (en) | Novel lipase gene and process for the production of lipase with the use of the same | |
| DK0832245T4 (da) | Rekombinant hexoseoxidase, en fremgangsmåde til at fremstille samme samt anvendelse af et sådan enzym | |
| AU7508794A (en) | Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase | |
| WO1988004657A3 (fr) | Inhibiteurs de la biosynthese du cholesterol a base de trans-6-[2-[2-(phenyle substitue)-3-(ou 4-) heteroaryl-5-substitue-1h-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2h-pyran-2-one | |
| AU6702296A (en) | Method for enhancing the activity of an enzyme, compounds showing enzyme activity enhancement, and detergents containing such compounds | |
| CY2216B1 (en) | Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof | |
| AU7468894A (en) | Process for the enzymatic preparation of optically active n-substituted-3-pyrrolidinol | |
| AU9257998A (en) | Method for enhancing the activity of an enzyme | |
| AU5159393A (en) | Process for preparing felbamate, 2-phenyl-1,3-propanediol and intermediates | |
| EP0283123A3 (fr) | Produits intermédiaires et procédé de préparation d'inhibiteurs de réductase HMG-COA | |
| AU1553001A (en) | Process for the production of optically active cyclohexene derivatives and intermediates therefor | |
| IL85836A (en) | Process for the synthesis of alpha-(1-methylethyl)-3,4-di-methoxybenzeneacetonitrile,and novel intermediates therefor | |
| EP0909757A3 (fr) | Procédé de préparation de dérivés de pentanetetraol optiquement actif | |
| AU5066898A (en) | Optically active methoxyiminoacetamide derivatives, process for the preparation of them, intermediates therefor, and pesticides containing them as the active ingredient | |
| AU6052090A (en) | Process for producing antibacterial intermediates via enzyme hydrolysis of racemic substrates | |
| EP0869185A3 (fr) | Préparation d'un composé sphingoide optiquement actif | |
| AU4708697A (en) | Process for the preparation of eberconazol and intermediates thereof | |
| AU4396599A (en) | Process for the preparation of optically active 1-arylalkylamines and intermediates therefor | |
| AU5575898A (en) | Process for producing optically active benzylsuccinic acid and intermediate therefor | |
| GB2359553B (en) | Processes for the preparation of optically active enones and intermediates thereof | |
| AU3693297A (en) | Process for the preparation of optically active anthracyclinones and intermediates thereof | |
| AU2003200812B2 (en) | Method of screening for enzyme activity | |
| AU2663900A (en) | Method for carrying out enzyme reactions by simultaneous enzymatic reaction and chromatography, notably for the separation of optical isomers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |